Buy divislab for Intraday Target 1222 with Stoploss below 1202
DIVISLAB has been in a long downtrend followed by a lengthy consolidation. It has just broken above the range and looks good for follow through. The logical first target is 710 and eventually, if the rally sustains, it should fill the gap at 760
Divis Laboratories' stock has been technically damaged by sudden burst of bubble. Only hunky-dory sector in Indian stock market which can stand on its foot is pharma after much publicized IT sector. Pharmaceutical companies stocks are like runaway trains, exhibiting near vertical rise on the charts. There is no way that this can continue forever. We did...